Edition:
United States

MediciNova Inc (MNOV.OQ)

MNOV.OQ on NASDAQ Stock Exchange Global Market

11.93USD
21 Sep 2018
Change (% chg)

$-0.27 (-2.21%)
Prev Close
$12.20
Open
$12.20
Day's High
$12.20
Day's Low
$11.88
Volume
117,942
Avg. Vol
30,466
52-wk High
$14.50
52-wk Low
$5.66

Chart for

About

Medicinova, Inc. is a biopharmaceutical company. The Company focuses on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical needs and a commercial focus on the United States market. Its pipeline includes MN-166 (ibudilast), MN-001 (tipelukast), MN-221 (bedoradrine) and MN-029... (more)

Overall

Beta: -0.25
Market Cap(Mil.): ¥51,954.49
Shares Outstanding(Mil.): 41.88
Dividend: --
Yield (%): --

Financials

  MNOV.OQ Industry Sector
P/E (TTM): -- 108.45 32.71
EPS (TTM): -40.66 -- --
ROI: -24.00 1.54 12.72
ROE: -25.23 0.30 14.84

BRIEF-MediciNova to collaborate with UCLA researchers in grant-funded clinical trial of MN-166 (ibudilast) in alcohol use disorder and withdrawal

* Says it plans to initiate a clinical trial of MN-166 (ibudilast) in alcohol dependence and withdrawal in collaboration with researchers at the University of California, Los Angeles (UCLA)

May 07 2018

Earnings vs. Estimates